Graduate student and Doctoral Academy Fellow Ellen Brune is taking her research beyond the lab.
Engineering researchers at the U of A have developed a method to simplify the pharmaceutical production of proteins used in drugs that treat a variety of diseases and health conditions, including diabetes, cancer, arthritis and macular degeneration. Ellen Brune, a doctoral student in chemical engineering is the primary researcher and inventor of the technology. With assistance from the National Science Foundation Innovation Corps program, she has started a company, Boston Mountain Biotech LLC, to shorten development time so that new drugs can get to patients faster. Current protein pharmaceutical development is a complicated, time-consuming and expensive process because manufacturers must separate and extract contaminant proteins.
Read more on the Arkansas Newswire